Paper
0
Phase 2 Study of aTezolizumab, bevAcizumab, and Cobinetinib (TACo) in patients (pts) with PD1 refractory metastatic brain metastases (MBM)
Authors
Journal
Published
Jan 1, 2024
Show more
Save
Tip0
TipSave
Abstract
Paper PDF
This PDF hasn't been uploaded yet.
Do not upload any copyrighted content to the site, only open-access content.
or